Medical Device AI Compliance in the San Francisco Bay Area (2026): Complete Checklist
The San Francisco Bay Area is the largest concentration of healthcare AI companies in the United States — and four California laws took effect January 1, 2026 that apply to every one of them. AB 489, AB 3030, AB 2013, and SB 1120 create disclosure, transparency, and human-oversight obligations that apply on top of FDA clearance. This is the checklist Bay Area health systems use to evaluate AI vendors.
Why the Bay Area Faces the Highest Compliance Visibility
The San Francisco Bay Area — including San Francisco, San Jose, Oakland, and the Peninsula — is home to the highest concentration of healthcare AI companies in the United States. The region captures approximately 40% of US digital health venture funding. Rock Health, the digital health accelerator based in San Francisco, reports over 600 active digital health companies with a Bay Area presence.
This concentration means Bay Area companies are disproportionately visible to California enforcement authorities. The Medical Board of California has explicitly named "large platforms and major metropolitan health technology vendors" as priority enforcement targets. Companies headquartered in San Francisco, Redwood City, San Mateo, and Palo Alto — which serve California patients — have the highest enforcement risk profile of any cohort in the state.
The critical distinction: FDA clearance evaluates device safety and efficacy. California's 2026 AI laws govern how cleared devices communicate with patients, handle AI-generated clinical content, and document their training data. A cleared diagnostic AI that sends unreviewed AI-generated summaries to patients violates AB 3030 regardless of its 510(k) status.
The Four Laws: Side-by-Side Reference
| Law | What It Requires | Who It Hits | Penalty |
|---|---|---|---|
| AB 489 | AI must disclose it is not human at start of every patient interaction | All patient-facing AI | Medical Board disciplinary action |
| AB 3030 | GenAI clinical communications need human review or specific disclaimer | Healthcare providers using GenAI | $2,500/violation + full liability |
| AB 2013 | Public training data disclosure required on your domain | GenAI developers and deployers | AG enforcement; blocks hospital procurement |
| SB 1120 | AI cannot autonomously deny health insurance claims | Utilization management AI tools | Regulatory action; contract liability |
AB 489 — AI Identity Disclosure for Bay Area Products
AB 489 prohibits any AI system from implying it is a licensed healthcare professional and requires a clear disclosure at the start of every patient interaction. For Bay Area digital health companies, common violation patterns include:
- Consumer health AI apps with conversational interfaces that answer medical questions without disclosing AI identity
- Mental health companion apps where the AI is designed to feel "human" to maximize engagement
- Remote patient monitoring platforms with AI-driven follow-up messaging that uses first-person clinical language
- Telehealth triage bots that ask symptom questions before routing to a physician
High-risk Bay Area product category
AI mental health companions and chronic disease management apps — common Bay Area digital health categories — are among the highest AB 489 enforcement risks. Designing for therapeutic alliance ("feels human" UX) without a compliant disclosure at session start is the most frequent pattern regulators have flagged in guidance documents.
AB 3030 — Generative AI in Clinical Communications
AB 3030 applies whenever generative AI produces clinical content sent directly to patients. Bay Area health technology companies most frequently encounter this requirement when:
- LLM-generated care gap messages are sent through patient portals without clinician review
- AI-written post-visit summaries are automatically delivered to patients after telehealth encounters
- Automated prescription refill reminders or adherence coaching messages are drafted by an LLM based on EHR data
- AI health coaching platforms send daily personalized messages generated from sensor or survey data
Compliance requires either: (1) a licensed clinician reviews and approves each AI output before it reaches the patient, or (2) every AI-generated clinical communication carries a specific disclaimer stating it was produced by AI, was not reviewed by a human provider, and includes instructions for reaching one.
AB 2013 — Training Data Transparency for Bay Area LLM Companies
AB 2013 is the law most frequently missed by Bay Area AI startups because it targets the model development side — not the user-facing product. The Bay Area's density of LLM development and fine-tuning activity makes this especially relevant. AB 2013 applies to any company that:
- Trains a generative AI model from scratch on any dataset
- Fine-tunes a foundation model (including LLaMA, GPT, Gemini, Claude) on clinical or proprietary data
- Applies RLHF, RLAIF, or other alignment training using human-rated healthcare outputs
- Builds a RAG system using proprietary clinical knowledge bases as the retrieval corpus
The public disclosure must be hosted at a publicly accessible URL on your own domain — not embedded in a terms of service, not gated behind a login, not linked from a privacy policy. UCSF Health and Stanford Health Care are beginning to require the AB 2013 disclosure URL as part of vendor risk assessments.
Free tool: Generate your AB 2013 disclosure
Use our free AB 2013 Training Data Transparency Generator to create a compliant, ready-to-publish disclosure page. Input your data categories and get publication-ready HTML in minutes. No signup required.
Open Transparency Generator →SB 1120 — No Autonomous Claim Denials
Several Bay Area health technology companies build utilization management and prior authorization AI tools. SB 1120 directly prohibits AI from being the final decision-maker on health insurance coverage denials. A licensed, qualified clinician must make the determination. If your platform generates clinical assessments used in payer utilization review workflows — even as supporting documentation — your contracts with health plans and hospital-operated health plans should explicitly address SB 1120 compliance requirements.
What Bay Area Health Systems Require at Vendor Procurement
Major San Francisco Bay Area health systems — including UCSF Medical Center, Stanford Health Care, Sutter Health, Kaiser Permanente Northern California, and Dignity Health — have updated AI vendor risk assessments. Compliance documentation typically requested includes:
- Screenshots or screen recordings demonstrating AB 489 disclosure in the live patient-facing product
- Written AB 3030 workflow policy identifying which communications receive human review, or the exact disclaimer language used on automated outputs
- The public URL of the company's AB 2013 training data disclosure page
- Attestation that no AI component autonomously issues clinical determinations without human oversight
- Audit log samples showing AI output timestamps, reviewer identities, and approval records
Bay Area hospital procurement timelines are typically 6–18 months. Compliance gaps identified during vendor review can stall or disqualify deals without a formal rejection notice.
The 2026 Bay Area MedTech AI Compliance Checklist
AB 489 — Patient-Facing AI Identity
- ☐ Every patient-facing AI interaction starts with a clear, prominent AI identity disclosure
- ☐ Disclosure appears before any clinical content is exchanged — not after
- ☐ Disclosure reappears at the start of every new session
- ☐ AI avatars carry no clinical camouflage (no white coats, stethoscopes, "Dr." or "Nurse" titles)
- ☐ Disclosure explicitly states the system is not a licensed healthcare professional
- ☐ Every AI interaction provides a clear pathway to reach a human staff member
AB 3030 — Generative AI Patient Communications
- ☐ All AI-generated patient communications are inventoried and classified
- ☐ For each type: human review workflow is documented OR disclaimer is deployed
- ☐ Human review policy names specific licensed reviewers with their credentials
- ☐ AI-generated communications sent without review carry the full AB 3030 disclaimer
- ☐ Disclaimer includes instructions for the patient to reach a human provider
- ☐ Audit logs capture AI outputs, reviewer identities, approval decisions, and timestamps
AB 2013 — Training Data Transparency
- ☐ Training data disclosure is published at a public URL on your domain
- ☐ Disclosure names all data categories — licensed, scraped, synthetic, proprietary
- ☐ HIPAA-regulated data use is documented with de-identification method specified
- ☐ Modification history section covers all substantial retraining events
- ☐ Disclosure URL is included in all hospital and payer vendor questionnaire responses
- ☐ A process exists to update the disclosure when the model is substantially retrained
SB 1120 — Utilization Management (if applicable)
- ☐ AI does not autonomously issue coverage denials or final clinical determinations
- ☐ Utilization management vendor contracts require SB 1120-compliant human review
- ☐ Licensed clinician review is documented for every denial where AI was involved
30-Day Compliance Action Plan for Bay Area Startups
Week 1 — Audit and map. Identify every AI touchpoint in your product that communicates with patients or generates clinical content. List which law applies to each. Flag every gap where no disclosure exists and where AI outputs reach patients without human review.
Week 2 — Fix AB 489 disclosures. Add clear AI identity disclosures to every patient-facing interaction. Audit AI avatar designs for clinical camouflage. Use our free Disclosure Generator to create compliant disclosure text for each product entry point.
Week 3 — Implement AB 3030 workflows. Either assign licensed reviewers to AI-generated clinical communications or deploy AB 3030 disclaimers on automated outputs. Build audit log infrastructure to capture reviewer actions and timestamps.
Week 4 — Publish AB 2013 disclosure and prepare procurement docs. Generate and publish your training data transparency page using our free AB 2013 Transparency Generator. Compile a procurement documentation package with disclosure screenshots, workflow policies, your AB 2013 URL, and audit log samples ready for UCSF, Stanford, or any Bay Area health system vendor review.
Penalties and Enforcement
All four laws took effect January 1, 2026. The Medical Board of California and California Attorney General's office have signaled active enforcement intent for 2026, with large platform operators and Bay Area health technology companies among the highest-visibility targets. AB 3030 penalties reach $2,500 per violation — per patient interaction lacking a required disclosure. For a Bay Area product serving tens of thousands of patients, a systemic disclosure gap creates aggregate exposure in the millions.
The California Attorney General has civil enforcement authority over AB 2013. Failure to publish a training data disclosure may be cited as a deceptive business practice under California's Unfair Competition Law (Business and Professions Code §17200), which allows injunctive relief, civil penalties, and restitution.